Resmetirom
MGL-3196-27
Phase 2 small_molecule active
Quick answer
Resmetirom for MASH - Metabolic Dysfunction-Associated Steatohepatitis is a Phase 2 program (small_molecule) at Madrigal Pharmaceuticals EU Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Madrigal Pharmaceuticals EU Limited
- Indication
- MASH - Metabolic Dysfunction-Associated Steatohepatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active